Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)

NCT00482612 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Esmirtazapine
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC